Quantcast

Latest Clinical pharmacology Stories

2014-08-19 23:13:18

On August 12, Wellspring Pharmaceutical Corporation announced that one lot of IPM Wound Gel is recalled due to microbial contamination. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 19, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on IPM Wound Gel. Wellspring Pharmaceutical Corporation...

2014-08-19 08:30:53

MALVERN, Pa., Aug. 19, 2014 /PRNewswire/ -- SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of late-stage pharmaceutical products for the treatment of pain, announced that it had formed a Scientific Advisory Board composed of four members: Dr. Jeff Gudin, Dr. Charles Argoff, Dr. Srinivas Nalamachu and Mr. Kip Vought. SCILEX Chief Executive Officer Anthony Mack said the expertise of this board would greatly assist in the development and...

2014-08-19 08:30:02

BELLEVILLE, ON, Aug. 19, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that it is targeting Q1/2015 for the filing of a Biologics License Application (BLA) with the United States Food and Drug Administration (FDA) for Bioniche's lead program Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) for the treatment of patients with high grade non-muscle invasive bladder cancer that have failed Bacillus Calmette-Guérin (BCG) therapy. This projected timeline...

2014-08-18 16:23:29

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Inflammatory Skin Diseases-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278593/-Inflammatory-Skin-Diseases-Pipeline-Insights-2014.html SUMMARYDelveInsight's," Inflammatory Skin Diseases-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the...

2014-08-18 16:23:26

LONDON, Aug. 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Impetigo-Pipeline Insights, 2014https://www.reportbuyer.com/product/2278589/-Impetigo-Pipeline-Insights-2014.html SUMMARYDelveInsight's," Impetigo-Pipeline Insights, 2014", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Impetigo. This report...

2014-08-18 12:26:58

BETHESDA, Md., Aug. 18, 2014 /PRNewswire/ -- Pinney Associates, Inc. is pleased to welcome Bethea (Annie) Kleykamp, PhD, to our Clinical Pharmacology team. Dr. Kleykamp will be responsible for development of evidence-based literature reviews and other science-based reports on topics including clinical pharmacology, pharmaceutical risk management, abuse potential assessment and abuse deterrent drug products, Rx-to-OTC switch, and consumer health....

2014-08-14 23:01:16

The Firm is representing numerous individuals who allegedly suffered life-threatening cardiovascular injuries prior to the 2012 NaturaLyte and GranuFlo recall. New York, NY (PRWEB) August 14, 2014 A U.S. Food and Drug Administration (FDA) initiative that allows public access to product recall information reveals that actions similar to one that has since prompted thousands of GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) have increased dramatically over the past few years,...

2014-08-11 16:28:42

Tennessee Doctor, Who Survived Substance Abuse, Says Similar Actions in Tennessee Have Saved Lives, Money SANTA MONICA, Calif., Aug. 11, 2014 /PRNewswire-USNewswire/ -- Proposition 46 can save California taxpayers up to $406 million annually by requiring doctors to check California's statewide prescription drug database before prescribing narcotics to first time patients, according to a report released by Consumer Watchdog today. Dr. Stephen Loyd, a recovering prescription drug addict from...

2014-08-11 08:29:12

Meeting with FDA Clarifies Path Forward CASTLE ROCK, Colo., Aug. 11, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1(TM) Test, a rapid, multi-analyte assay for aiding in identifying children, adolescent and young adult patients who are at low risk for appendicitis, will host an investor conference call to discuss business updates, including discussion on the progress of...

2014-08-08 08:25:39

REDWOOD CITY, Calif., Aug. 8, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will be participating at three upcoming investor events. Details of the three events are as follows: Canaccord 34(th) Annual Growth ConferenceDate: Wednesday August 13(th) Location: Boston,...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related